Neuraxpharm

    OverviewSuggest Edit

    Neuraxpharm is a pharmaceutical company focusing on the treatment of central nervous system (CNS) disorders. It focuses on antipsychotics, antidepressants, antiepileptics, antiparkinson, tranquilizers, providing medicines, generics, and consumer healthcare products, such as probiotics and other nutraceuticals.
    TypePrivate
    Founded1985
    HQLangenfeld (Rheinland), DE
    Websiteneuraxpharm.com

    Latest Updates

    Employees (est.) (Sept 2021)406(+3%)
    Cybersecurity ratingBMore

    Key People/Management at Neuraxpharm

    Jörg-Thomas Dierks

    Jörg-Thomas Dierks

    CEO
    Lluís Pérez

    Lluís Pérez

    Chief Financial Officer
    Aida Fernandez

    Aida Fernandez

    Chief Human Resources Officer
    Christoph Koch

    Christoph Koch

    Chief Business Development Officer
    Francisco Jurado

    Francisco Jurado

    Chief Scientific Officer
    Dan Furrer

    Dan Furrer

    Chief Marketing Officer
    Show more

    Neuraxpharm Office Locations

    Neuraxpharm has offices in Langenfeld (Rheinland), Gießhübl, Hradec Králové, Paris and in 5 other locations
    Langenfeld (Rheinland), DE (HQ)
    Elisabeth-Selbert-Straße 23
    Gießhübl, AT
    Perlhofgasse 2
    Hradec Králové, CZ
    20a, Smetanovo nábř. 1238
    Paris, FR
    84 Rue de Grenelle
    Ascoli Piceno, IT
    Via Piceno Aprutina, 47
    Warszawa, PL
    Zepter Business Centre, Domaniewska 37
    Show all (10)

    Neuraxpharm Financials and Metrics

    Summary Metrics

    Founding Date

    1985

    Neuraxpharm Cybersecurity Score

    Cybersecurity ratingPremium dataset

    B

    81/100

    SecurityScorecard logo

    Neuraxpharm Online and Social Media Presence

    Embed Graph

    Neuraxpharm News and Updates

    Panaxia and Neuraxpharm Expands Strategic Collaboration to Poland

    TEL AVIV, Israel, Aug. 19, 2021 /PRNewswire/ -- Panaxia Labs Israel Ltd. ("Panaxia Israel"), (TASE: PNAX), a global pharma company, specializes in developing, manufacturing and marketing advanced medical cannabis products in pharmaceutical quality and its partner, Neuraxpharm, Europe's...

    Neuraxpharm appoints commercial expert Dr. Maximilian von Wülfing as Chief Operating Officer

    DÜSSELDORF, Germany and BARCELONA, Spain, June 1, 2021 /PRNewswire/ -- Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the central nervous system (CNS), announces today that Dr. Maximilian von Wülfing has been appointed Chief Operating...

    Neuraxpharm launches first product in Japan

    DÜSSELDORF, Germany and BARCELONA, Spain, Jan. 12, 2021 /PRNewswire/ -- Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the central nervous system (CNS), today announces the launch in Japan of the recently acquired prescription brand...

    Neuraxpharm establishes operations in the Republic of Ireland through the acquisition of Medinutrix

    DÜSSELDORF, Germany and BARCELONA, Spain, Dec. 14, 2020 /PRNewswire/ -- Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on disorders of the central nervous system (CNS), today announces the expansion of its operations in Northwestern Europe...

    Tris Pharma and Neuraxpharm Group Announce Partnership to Commercialize Tris' Quillivant XR and Quillichew ER in Europe

    MONMOUTH JUNCTION, N.J., DÜSSELDORF, Germany and BARCELONA, Spain, Dec. 8, 2020 /PRNewswire/ -- Tris Pharma, Inc. ("Tris"), a specialty pharmaceutical company with a robust portfolio of FDA-approved products for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and related...

    Panaxia and Neuraxpharm Expand Strategic Collaboration to France with medical cannabis

    TEL AVIV, Israel, Nov. 23, 2020 /PRNewswire/ -- Panaxia Global, the controlling owner of Panaxia Labs Israel Ltd. ("Panaxia Israel"), (TASE: PNAX), Israel's largest manufacturer of medical cannabis products, and its partner, Neuraxpharm, Europe's leading pharmaceutical company specialized...
    Show more

    Neuraxpharm Frequently Asked Questions

    • When was Neuraxpharm founded?

      Neuraxpharm was founded in 1985.

    • Who are Neuraxpharm key executives?

      Neuraxpharm's key executives are Jörg-Thomas Dierks, Lluís Pérez and Aida Fernandez.

    • How many employees does Neuraxpharm have?

      Neuraxpharm has 406 employees.

    • Who are Neuraxpharm competitors?

      Competitors of Neuraxpharm include Strides Pharma, Chiesi Group and Cadila Pharmaceuticals.

    • Where is Neuraxpharm headquarters?

      Neuraxpharm headquarters is located at Elisabeth-Selbert-Straße 23, Langenfeld (Rheinland).

    • Where are Neuraxpharm offices?

      Neuraxpharm has offices in Langenfeld (Rheinland), Gießhübl, Hradec Králové, Paris and in 5 other locations.

    • How many offices does Neuraxpharm have?

      Neuraxpharm has 10 offices.